Pluri (PLUR) Accumulated Expenses (2011 - 2025)
Pluri (PLUR) posted quarterly Accumulated Expenses of $566000.0 for Q4 2025, down 32.7% year-over-year from $841000.0 in Q4 2024, and down 35.97% quarter-over-quarter from $884000.0 in Q3 2025.
Pluri (PLUR) Accumulated Expenses (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Accumulated Expenses for 15 consecutive years, with $566000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Accumulated Expenses fell 32.7% year-over-year to $566000.0; the TTM figure through Dec 2025 stood at $566000.0 (down 32.7% YoY), while the FY2025 annual figure was $1.2 million, down 3.68% from the prior year.
- Accumulated Expenses retreated to $566000.0 in Q4 2025 per PLUR's latest filing, from $884000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $2.2 million in Q1 2021 and bottomed at $566000.0 in Q4 2025.
- Historically, Accumulated Expenses has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
- Annual changes were most pronounced in 2021 — Accumulated Expenses slumped 79.72% — and 2022, when it jumped 166.34%.
- Pluri's Accumulated Expenses stood at $1.5 million in 2021, then climbed by 3.79% to $1.5 million in 2022, then tumbled by 34.9% to $981000.0 in 2023, then fell by 14.27% to $841000.0 in 2024, then slumped by 32.7% to $566000.0 in 2025.
- Business Quant data shows PLUR's Accumulated Expenses at $566000.0 in Q4 2025, $884000.0 in Q3 2025, and $1.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 566,000.00 |
| Sep 30, 2025 | 884,000.00 |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 841,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 952,000.00 |
| Dec 31, 2023 | 981,000.00 |
| Sep 30, 2023 | 993,000.00 |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.63 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.42 Mn |
| Jun 30, 2021 | 612,000.00 |
| Mar 31, 2021 | 2.19 Mn |